Related references
Note: Only part of the references are listed.Association between TH2 Cytokine Gene Polymorphisms and Risk of Bullous Pemphigoid
Pardis-Sadat Tabatabaei-Panah et al.
IMMUNOLOGICAL INVESTIGATIONS (2022)
Prominent Role of Type 2 Immunity in Skin Diseases-Beyond Atopic Dermatitis
Lina Belmesk et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2022)
Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms
Connor Cole et al.
FRONTIERS IN IMMUNOLOGY (2022)
Current and Innovated Managements for Autoimmune Bullous Skin Disorders: An Overview
Kuan-Yu Chu et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
S. Morteza Seyed Jafari et al.
FRONTIERS IN IMMUNOLOGY (2021)
The New Era of Biologics in Atopic Dermatitis: A Review
Simon Schneider et al.
DERMATOLOGY PRACTICAL & CONCEPTUAL (2021)
Dupilumab successfully treated refractory bullous pemphigoid with early clinical manifestations imitating atopic dermatitis: A case letter
Yihua Zhang et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2021)
Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series
Rana Abdat et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Anti-BP180 autoantibody levels at diagnosis correlate with 1-year mortality rates in patients with bullous pemphigoid
B. Monshi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)
Hideyuki Ujiie et al.
JOURNAL OF DERMATOLOGY (2019)
Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid
Alex Kaye et al.
JAMA DERMATOLOGY (2018)
An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone
M. Sticherling et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Dedee F. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)